RAD51 and ovarian cancer: However, in spite of the importance of HR alteration in hereditary breast/ovarian cancer, mutations of the pivotal HR player RAD51 are surprisingly absent from the lists of genes predisposing individuals to breast or ovarian cancer (Figure 1A and B).